In this study, we have performed a detailed characterization of the biological and clinical impact of MALAT1 deregulation in two types of indolent B cell lymphomas with different underlying pathobiological mechanisms, namely CLL and follicular lymphoma (FL). Here, MALAT1 is linked to follicular lymphoma.